
Psychosomatics 48:467-475, November-December
doi: 10.1176/appi.psy.48.6.467
© 2007 Academy of Psychosomatic Medicine
Psychosocial Aspects of Pulmonary Hypertension: A Review
John M. Wryobeck, Ph.D.,
Giuseppina Lippo, M.D.,
Valerie McLaughlin, M.D.,
Michelle Riba, M.D., and
Melvyn Rubenfire, M.D.
Received November 8, 2006; revised February 26, 2007; accepted March 16, 2007. From the Univ. of Toledo Dept. of Psychiatry; the Univ. of Michigan Dept. of Psychiatry; and the Univ. of Michigan, Division of Cardiovascular Medicine, Dept. of Internal Medicine. Send correspondence and reprint requests to John M. Wryobeck, Ph.D., Univ. of Toledo Health Science Campus; Dept. of Psychiatry; Mail Stop 1193, 3000 Arlington Ave.; Toledo, OH 43614. e-mail: John.Wryobeck{at}utoledo.edu
© 2007 The Academy of Psychosomatic Medicine
Pulmonary arterial hypertension (PAH) is characterized by progressive and sustained elevation of pulmonary-artery pressure, which ultimately leads to right-ventricular failure and death. The diagnosis carries with it an uncertain and historically very bleak prognosis. Although new oral and chronic parenteral (intravenous and subcutaneous) treatments have had a significant positive medical impact on the physical functioning of individuals with PAH, patients often struggle with new short- and long-term psychosocial challenges. The purpose of the current article is to 1) provide a brief review of PAH and its treatment; 2) summarize the limited literature examining the psychosocial adjustment of those with a PAH diagnosis; and 3) provide pertinent information extrapolated from the larger literature on chronic illness that might inform us on the psychosocial challenges faced by the patient diagnosed with PAH.
Get information about faster international access.
a>
Privacy Policy
Copyright © 2007
Academy of Psychosomatic Medicine.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|